Sign up to save your podcasts
Or
Share October 2024: Real-World Effectiveness of Menopausal Hormone Therapy in Preventing Relapse in Women With Schizophrenia or Schizoaffective Disorder
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
October 2024: Real-World Effectiveness of Menopausal Hormone Therapy in Preventing Relapse in Women With Schizophrenia or Schizoaffective Disorder
Dr. Bodyl Brand (Oxford University, UK) joins AJP Audio to discuss the effectiveness of menopausal hormone therapy in preventing psychosis relapse in women with schizophrenia and schizoaffective disorder. Afterwards, AJP Editor-in-Chief Dr. Ned Kalin takes us through the rest of the October issue of the American Journal of Psychiatry, which focuses on other issues touching psychosis and schizophrenia spectrum disorders.
- 01:05 Brand interview
- 03:08 MHT and potential side effects in schizophrenia treatment
- 06:16 Estrogen and psychosis prophylaxis
- 07:44 MHT effectiveness
- 10:15 Clinical implications
- 11:27 Strengths and limitations
- 13:47 The need for further study
- 15:54 Further research
- 17:24 Kalin interview
- 17:47 Brand et al.
- 20:17 Partanen et al.
- 23:54 Moran et al.
- 26:48 Gallucci et al.
- 30:38 Arion et al.
Transcript
Be sure to let your colleagues know about the podcast, and please rate and review it on Apple Podcasts, Google Podcasts, Spotify, or wherever you listen to it.
Subscribe to the podcast here.
Listen to other podcasts produced by the American Psychiatric Association.
Browse articles online.
How authors may submit their work.
Follow the journals of APA Publishing on Twitter.
E-mail us at [email protected]
View all episodes
By American Journal of Psychiatry
3.9
7373 ratings
Dr. Bodyl Brand (Oxford University, UK) joins AJP Audio to discuss the effectiveness of menopausal hormone therapy in preventing psychosis relapse in women with schizophrenia and schizoaffective disorder. Afterwards, AJP Editor-in-Chief Dr. Ned Kalin takes us through the rest of the October issue of the American Journal of Psychiatry, which focuses on other issues touching psychosis and schizophrenia spectrum disorders.
- 01:05 Brand interview
- 03:08 MHT and potential side effects in schizophrenia treatment
- 06:16 Estrogen and psychosis prophylaxis
- 07:44 MHT effectiveness
- 10:15 Clinical implications
- 11:27 Strengths and limitations
- 13:47 The need for further study
- 15:54 Further research
- 17:24 Kalin interview
- 17:47 Brand et al.
- 20:17 Partanen et al.
- 23:54 Moran et al.
- 26:48 Gallucci et al.
- 30:38 Arion et al.
Transcript
Be sure to let your colleagues know about the podcast, and please rate and review it on Apple Podcasts, Google Podcasts, Spotify, or wherever you listen to it.
Subscribe to the podcast here.
Listen to other podcasts produced by the American Psychiatric Association.
Browse articles online.
How authors may submit their work.
Follow the journals of APA Publishing on Twitter.
E-mail us at [email protected]
More shows like American Journal of Psychiatry Audio
View all
NEI Podcast
140 Listeners
Neurology® Podcast
297 Listeners
Journal of the American Academy of Child and Adolescent Psychiatry
28 Listeners
Core EM - Emergency Medicine Podcast
258 Listeners
Practical Neurology Podcast
46 Listeners
JAMA Psychiatry Author Interviews
20 Listeners
Psychiatric Services From Pages to Practice
26 Listeners
Psychiatry & Psychotherapy Podcast
1,350 Listeners
Real Life Pharmacology - Pharmacology Education for Health Care Professionals
730 Listeners
Psychopharmacology and Psychiatry Updates
292 Listeners
Psychoanalysis On and Off the Couch
168 Listeners
The Carlat Psychiatry Podcast
576 Listeners
The Curbsiders Addiction Medicine Podcast
120 Listeners
Psychiatry Boot Camp
189 Listeners
PsychRounds: The Psychiatry Podcast
149 Listeners